Main navigation
You are here
- Home
- Media
- Photo library
- Board and management
Board and management photo library
David Brennan
David Brennan
Chief Executive Officer
David Brennan was appointed Chief Executive Officer of AstraZeneca effective 1 Jan 2006. Read Biography
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
